OXFORD BIOMEDICA - Trademark Details
Status: 710 - Cancelled - Section 8
Image for trademark with serial number 77673768
Serial Number
77673768
Registration Number
3968293
Word Mark
OXFORD BIOMEDICA
Status
710 - Cancelled - Section 8
Status Date
2018-01-05
Filing Date
2009-02-19
Registration Number
3968293
Registration Date
2011-05-31
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2011-03-15
Attorney Name
Law Office Assigned Location Code
L60
Employee Name
SINGH, TEJBIR
Statements
Disclaimer with Predetermined Text
"OXFORD"
Goods and Services
Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; polypeptides for in vitro research use, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory, scientific and biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, namely, in vitro and in vivo use
Goods and Services
Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical treatment purposes; pharmaceuticals for medical purposes for the delivery of genes to cells; viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes; pre-filled vials for medical purposes and for pharmaceutical and biochemical preparations, for use in gene therapy and for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders
Goods and Services
Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, namely, medical syringes and injectors for medical purposes
Goods and Services
Scientific, pharmaceutical and medical research and development; genetic engineering services, biotechnology services, namely, research and development for new products in the field of biotechnology, advisory services relating to gene therapy products and clinical trials, conducting clinical trials
Goods and Services
Medical services; advisory services relating to vaccination regimes; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders and contraceptives
Pseudo Mark
OXFORD BIO MEDICAL
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2018-01-05
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2018-01-05
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2018-01-05
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2018-01-05
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2018-01-05
Primary Code
044
Correspondences
Name
HOWARD N. ARONSON
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2009-02-18008110744EMTrue
Trademark Events
Event DateEvent Description
2009-02-23NEW APPLICATION ENTERED IN TRAM
2009-02-23NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2009-02-24NOTICE OF PSEUDO MARK MAILED
2009-05-11ASSIGNED TO EXAMINER
2009-05-11NON-FINAL ACTION WRITTEN
2009-05-11NON-FINAL ACTION E-MAILED
2009-05-11NOTIFICATION OF NON-FINAL ACTION E-MAILED
2009-11-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2009-11-20ASSIGNED TO LIE
2009-11-20CORRESPONDENCE RECEIVED IN LAW OFFICE
2009-11-20TEAS/EMAIL CORRESPONDENCE ENTERED
2009-12-01SUSPENSION LETTER WRITTEN
2009-12-01LETTER OF SUSPENSION E-MAILED
2009-12-01NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2009-12-11SUSPENSION LETTER WRITTEN
2009-12-11LETTER OF SUSPENSION E-MAILED
2009-12-11NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2010-06-14SUSPENSION INQUIRY WRITTEN
2010-06-14INQUIRY TO SUSPENSION E-MAILED
2010-06-14NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2010-12-09TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2011-01-06ASSIGNED TO LIE
2011-01-06CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-01-06TEAS/EMAIL CORRESPONDENCE ENTERED
2011-01-31EXAMINERS AMENDMENT -WRITTEN
2011-01-31EXAMINERS AMENDMENT E-MAILED
2011-01-31NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2011-01-31EXAMINER'S AMENDMENT ENTERED
2011-01-31APPROVED FOR PUB - PRINCIPAL REGISTER
2011-02-08LAW OFFICE PUBLICATION REVIEW COMPLETED
2011-03-15PUBLISHED FOR OPPOSITION
2011-03-15OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2011-05-31REGISTERED-PRINCIPAL REGISTER
2018-01-05CANCELLED SEC. 8 (6-YR)